Table 1 Comparison of clinical characteristics between the two groups
Item | Symptomatic patients (N = 62) | Asymptomatic patients (N = 54) | t-value | P-value |
|---|---|---|---|---|
Gender (F/M) (χ2) | 14/48 | 12/42 | 0.974 | 1.000 |
Age (year) | 67.7 ± 8.8 | 64.7 ± 6.8 | 1.571 | 0.121 |
Height (cm) | 166.9 ± 6.4 | 166.6 ± 6.6 | 0.202 | 0.840 |
Weight (kg) | 64.0 ± 11.1 | 64.7 ± 10.6 | −0.247 | 0.805 |
Body mass index (kg/m2) | 22.8 ± 3.1 | 23.2 ± 2.8 | −0.681 | 0.497 |
SBP (mm Hg) | 137.5 ± 15.2 | 135.3 ± 17. 6 | 0.495 | 0.622 |
DBP (mm Hg) | 85.8 ± 9.3 | 85.7 ± 10.9 | 0.040 | 0.968 |
Diabetes mellitus type 2 (n) | 24.0 | 18.0 | 0.671 | 0.786 |
Hypertension (n) | 28.0 | 22.0 | 0.735 | 0.795 |
Fasting plasma glucose (m mol / L) | 6.1 ± 1.6 | 5.7 ± 1.4 | 0.838 | 0.407 |
Total cholesterol (m mol / L) | 4.6 ± 1.2 | 4.5 ± 0.9 | 0.340 | 0.736 |
LDL cholesterol (m mol / L) | 2.9 ± 1.1 | 3.0 ± 0.8 | −0.397 | 0.693 |
Triglycerides (m mol / L) | 1.7 ± 1.3 | 1.3 ± 0. 8 | 1.061 | 0.295 |
Leukocytes (× 109/L) | 7.05 ± 2.33 | 6.01 ± 1.82 | 2.235 | 0.028 |
Lymphocytes (×109/L) | 1.67 ± 0.54 | 1.99 ± 0.91 | −1.929 | 0.047 |
Neutrophils (×109/L) | 4.59 ± 1.72 | 3.71 ± 1.59 | 2.409 | 0.018 |